Treatment updates

Southeast Kansas Center Highlights Spravato in Chanute

TMS Therapy Kansas editorial teamSource-backed reportingSeptember 27, 20262 min read
Editorial image for Southeast Kansas Center Highlights Spravato in Chanute
What changed

Southeast Kansas Mental Health Center says Spravato nasal spray was introduced at a certified Chanute provider for adults with treatment-resistant depression.

Spravato introduction highlighted

Southeast Kansas Mental Health Center highlighted the introduction of Spravato, an esketamine nasal spray, at a certified provider location in Chanute. The center described that location as the first certified provider in the region.

According to Southeast Kansas Mental Health Center, Spravato is an FDA-approved treatment designed for adults with treatment-resistant depression. The announcement identifies the treatment as a nasal spray and describes its introduction as a new treatment option in the area.

What the source says about symptoms

Southeast Kansas Mental Health Center said Spravato has shown rapid symptom improvement, often within 24 hours. The source presents that timeframe as part of its description of the treatment for adults with treatment-resistant depression.

The announcement does not provide additional details about how the treatment is delivered, which adults may be eligible, or how access is arranged. Southeast Kansas Mental Health Center also does not provide information in the supplied extract about insurance coverage, costs, referrals, appointment availability, or follow-up care.

A treatment update for the region

The Southeast Kansas Mental Health Center announcement focuses on the arrival of an FDA-approved esketamine nasal spray treatment at a certified Chanute location. The center says the site is the first certified provider in the region.

The source describes Spravato specifically for adults with treatment-resistant depression. It does not describe the treatment as being intended for children or teenagers, and it does not provide broader information about other mental health conditions.

What this means for Kansas patients

For people looking for treatment options locally, this announcement identifies a treatment update in Chanute while noting that Spravato is designed for adults with treatment-resistant depression, according to Southeast Kansas Mental Health Center. The directory lists 37 published clinics in Kansas, which may help patients identify treatment locations in their area.

This is general information, not medical advice.

More Kansas reporting on treatment updates.

This report is educational and is not medical advice. Coverage, availability and eligibility can change; verify details with the named source or your care team.

Related Kansas updates

Find a Provider